Related Experiment Video
Updated: Jan 31, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain
Justin K Lui1, Matthew Cozzolino2, Morgan Winburn2
1The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Objectives:
The objective of the study was to explore left atrial (LA) strain, a quantitative index of left ventricular (LV) diastolic function, in risk stratifying patients with SSc-related pulmonary hypertension (SSc-PH).
Methods:
This was an exploratory, retrospective single-centre study of 124 patients with SSc-PH confirmed on right heart catheterization. We quantified and clustered the three components of LA global longitudinal strain (GLS): (i) reservoir (systole); (ii) conduit (early diastole); and (iii) contractile (late diastole), using echocardiograms closest to timing of right heart catheterization. We applied both the Kaplan-Meier method and a Cox proportional hazards model to determine associations with our primary outcome of all-cause mortality.
Results:
Using k-means clustering, we divided our cohort into three clusters: Cluster 1 (N = 40), Cluster 2 (N = 34) and Cluster 3 (N = 50). Compared with Cluster 1, Cluster 2 had the lowest median LA conduit strain, and Cluster 3 exhibited the lowest median LA contractile strain. There was a statistically significant difference in survival between clusters (log-rank P = 0.005). Median survival was 122.4 months, 67.9 months and 48.4 months for Cluster 1, Cluster 2 and Cluster 3, respectively. Compared with those in Cluster 1, patients in Cluster 2 and Cluster 3 had adjusted hazard ratios of 1.46 (95% CI: 0.71, 2.97) and 2.57 (95% CI: 1.32, 5.02) for all-cause mortality, respectively.
Conclusion:
Of the three LA GLS clusters, Cluster 3 had the shortest median survival. LA GLS may provide further risk stratification of patients with SSc-PH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Overview of Systemic and Pulmonary Circulation
The oxygenated blood is sent...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Stratified Sampling Method
To choose a stratified sample, divide the population into groups called strata and then take a...

